CD47 and atherosclerosis: Since angiotensin II promotes release of pro-inflammatory cytokines33, it is possible that blockade of CD47 in the setting of angiotensin treated hypercholesteremic mice might have a larger impact on efferocytosis and a beneficial effect on atherosclerosis.